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Summary
 
We investigated the role of antigen-presenting cells in early interferon (IFN)-
 
g
 
 production in
normal and recombinase activating gene 2–deficient (Rag-2
 
2/2
 
) mice in response to 
 
Listeria
monocytogenes
 
 (LM)
 
 
 
infection and interleukin (IL)-12 administration. Levels of serum IFN-
 
g
 
 in
Rag-2
 
2/2
 
 mice were comparable to those of normal mice upon either LM infection or IL-12
injection. Depletion of natural killer (NK) cells by administration of anti-asialoGM1 antibodies
had little effect on IFN-
 
g
 
 levels in the sera of Rag-2
 
2/2
 
 mice after LM infection or IL-12 injec-
tion. Incubation of splenocytes from NK cell–depleted Rag-2
 
2/2
 
 mice with LM
 
 
 
resulted in the
production of IFN-
 
g
 
 that was completely blocked by addition of anti–IL-12 antibodies. Both
dendritic cells (DCs) and monocytes purified from splenocytes were capable of producing IFN-
 
g
 
when cultured in the presence of IL-12. Intracellular immunofluorescence analysis confirmed
the IFN-
 
g
 
 production from DCs. It was further shown that IFN-
 
g
 
 was produced predomi-
nantly by CD8
 
a
 
1
 
 lymphoid DCs rather than CD8
 
a
 
2
 
 myeloid DCs. Collectively, our data in-
dicated that DCs are potent in producing IFN-
 
g
 
 in response to IL-12 produced by bacterial in-
fection and play an important role in innate immunity and subsequent T helper cell type 1
development in vivo.
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D
 
endritic cells (DCs) are bone marrow (BM)-derived
professional APCs. Peripheral DCs are characterized by
high capability for antigen capture and processing, migration
to lymphoid organs, and expression of various costimulatory
molecules for antigen-specific lymphocyte activation. Cyto-
kine secretion by DCs initiates and enhances both innate
and acquired immunity (1).
Activation of macrophages and DCs by infectious agents
leads to secretion of IL-12, which subsequently induces
IFN-
 
g
 
 production by NK cells and directs Th1 develop-
ment. IFN-
 
g
 
, in turn, acts on monocytes to augment IL-12
secretion and to produce nitric oxide that eradicates infected
microbes (2, 3). Thus, IL-12 and IFN-
 
g
 
 comprise a positive
feedback system, which is probably required for optimal
production of IL-12 in vivo (4, 5). Studies using neutraliz-
 
ing Abs against IFN-
 
g
 
 and mice deficient for IL-12 or IFN-
 
g
 
have confirmed the importance of these cytokines for innate
immunity and Th1 development for controlling intracellu-
lar pathogens (6–11).
It was generally assumed that the only cells producing
IFN-
 
g
 
 in response to IL-12 are NK and T cells. However,
recent studies have shown that IFN-
 
g
 
 is also produced by
peritoneal macrophages in response to IL-12 and by BM-
derived macrophages in response to a combination of IL-12
and IL-18, suggesting the presence of an autocrine activa-
tion pathway (12, 13).
In the study presented here, we examined IFN-
 
g
 
 produc-
tion pathways in NK cell–depleted recombinase activating
gene 2–deficient (Rag-2
 
2/2
 
) mice upon 
 
Listeria monocytogenes
 
(LM) infection or IL-12 administration. We found that the
levels of IFN-
 
g
 
 produced in the sera of these mice were un-
altered as compared with those of Rag-2
 
2/2
 
 mice with NK
cells, suggesting an important role for a non-T, -B, and/or
-NK cell type(s) in producing IFN-
 
g
 
 in vivo. We show here
that purified DCs were capable of producing significant
amounts of IFN-
 
g
 
 in response to IL-12. Among DCs,
CD8
 
a
 
1
 
 lymphoid DCs are the major producers of IFN-
 
g
 
.
Thus, DCs produce IFN-
 
g
 
 in an autocrine manner by re- 
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sponding to the IL-12 they produce upon bacterial infection,
and such autocrine production of IFN-
 
g
 
 likely plays an im-
portant role in both innate and acquired immunity in vivo.
 
Materials and Methods
 
Mice.
 
B10.D2 and C57BL/6 mice were purchased from San-
kyo Labo Service Co. Inc. (Japan). B10.D2–Rag-2
 
2/2
 
 mice, gen-
erated by backcross of Rag-2
 
2/2
 
 mice to B10.D2/nSnJ for 10
generations (reference 14 and unpublished data) were obtained
from Taconic Farms. C57BL/6-Rag-2
 
2/2
 
 mice which also lack the
cytokine receptor common 
 
g
 
 chain [hereafter C57BL/6-
 
g
 
c
 
2/2
 
(Y)
 
Rag-2
 
2/2
 
 mice], were made as follows. Rag-2
 
2/2
 
 (14) and 
 
g
 
c
 
2/2
 
(Y)
 
mice (15) were backcrossed to C57BL/6 for eight generations and
intercrossed to generate C57BL/6-Rag-2
 
2/2
 
 and C57BL/6-
 
g
 
c
 
2/2
 
(Y)
 
mice. These mice were further bred to generate C57BL/6-
 
g
 
c
 
2/2
 
(Y)
 
Rag-2
 
2/2
 
 mice. NOD/LtSz-scid/scid mice (16) were provided
by N. Hozumi of Science University of Tokyo (Tokyo, Japan) and
J. Hata of Keio University School of Medicine (Tokyo, Japan).
All mice were maintained in our specific pathogen-free animal
facility, and experiments were performed on mice between 6 and
12 wk of age, in accordance with our Institutional Guidelines.
 
Listeria monocytogenes. Listeria monocytogenes 
 
EGD strain (LM)
was provided by M. Mitsuyama of Kyoto University (Kyoto, Ja-
pan). The bacteria had been passed through C57BL/6 mice and
colonies were obtained from the spleens of infected mice on agar
plates with trypto-soy broth (Eiken Chemical Co., Japan). Bacte-
ria were then grown in trypto-soy broth overnight at 37
 
8
 
C. Ali-
quots of bacteria suspension were stored at 
 
2
 
80
 
8
 
C until use. After
thawing, 2 
 
3
 
 10
 
6
 
 LM were injected into mice intraperitoneally.
In some in vitro experiments, 10
 
6
 
 collagenase-treated splenocytes
were cultured with 4 
 
3
 
 10
 
5
 
 LM in a 96-well flat-bottomed plate.
After 45 min, penicillin and streptomycin were added to the cul-
ture media at final concentrations of 100 U/ml and 100 
 
m
 
g/ml,
respectively, to limit the growth of LM, and culture supernatants
were collected after 72 h and subjected to ELISA.
 
Cell Preparation.
 
Splenocytes were prepared by homogeniz-
ing collagenase-treated spleens in all experiments. DCs were pre-
pared from spleens as previously described (17). In brief, collage-
nase-treated spleens (Collagenase D; Boehringer Mannheim)
were homogenized and suspended in a dense BSA solution (
 
P
 
 5
 
1.080), overlaid with 1 ml of RPMI medium, and centrifuged in
a swing bucket rotor at 9,500 
 
g
 
 for 10 min at 4
 
8
 
C. DCs and mono-
cytes at the interface were collected, washed, and allowed to adhere
to plastic dishes for 2 h. Cells were incubated for an additional 18 h
to allow DCs to detach from the plastic dishes. Nonadherent cells
containing DCs were then collected and contaminated B cells were
further excluded by anti–mouse Ig(H
 
1
 
L)-beads (Perseptive Bio-
systems) using a MACS magnet (Miltenyi Biotech). After remov-
ing DCs, adherent macrophages were detached from the plastic
dishes by a cell scraper (Sumitomo Bakelite Co. Ltd., Japan). NK
cells were enriched by a combination of PK136-biotin (anti-
NK1.1) and Streptavidin-MicroBeads (Miltenyi Biotech). These
fractions were stained with appropriate mAbs and were further pu-
rified by cell sorting on a FACS Vantage™ (Becton Dickinson).
 
Antibodies and Flow Cytometric Analysis.
 
The following mAbs
were purchased from PharMingen: 145-2C11–FITC and 145-
2C11–PE (anti-CD3
 
e
 
); DX5-FITC (anti-Pan NK); PK136-PE
and PK136-biotin (anti-NK1.1); HL3-FITC and HL3-PE (anti-
CD11c); AF6-120.1-PE (anti-I-A
 
b
 
); 53-6.7-PE and 53-6.7-bio-
tin (anti-CD8
 
a
 
); M1/70-biotin (anti-CD11b); and PO3-biotin
(anti-CD86). F4/80-FITC (anti-pan macrophage) was purchased
 
from Caltag Labs. An mAb, Y3P (anti-pan-I-A), was purified
from hybridoma culture supernatants and conjugated with FITC.
Biotinylated mAbs were detected with streptavidin–Red 670
(GIBCO BRL). 1–2 
 
3
 
 10
 
6
 
 cells were stained in PBS/2% FCS,
washed, and analyzed on a FACScan
 
®
 
 using the CELLQuest pro-
gram (Becton Dickinson). Rabbit polyclonal anti-asialoGM1
(
 
a
 
ASGM1) and anti–IL-12 Abs were purchased from Wako Pure
Chemical Industries, Ltd. and PharMingen, respectively.
 
Cytokine Assays.
 
To induce IFN-
 
g
 
 in vivo, 0.5 
 
m
 
g IL-12 or
2 
 
3
 
 10
 
6
 
 LM were intraperitoneally injected into mice. In in vivo
experiments, cells were cultured in the presence of 1 ng/ml IL-12
for 72 h or 4 
 
3
 
 10
 
5
 
 LM as described above. Titers of IFN-
 
g
 
 in
the sera and culture supernatants were determined by Quantikine
M ELISA Kit (R&D Systems).
 
Intracellular Immunofluorescence Analysis.
 
Immunofluorescence
staining of intracellular IFN-
 
g
 
 was conducted as previously de-
scribed (18). Sorted DCs were grown on coverslips coated with
Cell-Tak7 (Becton Dickinson Labware) and fixed for 15 min
with 3.7% paraformaldehyde in PBS. After surface staining with
FITC-conjugated mAb against CD11c, cells were permeabilized
with 0.5% saponin/1% BSA in PBS for 30 min. Cells were further
incubated with polyclonal rabbit anti–mouse IFN-
 
g
 
 Ab (Pestka
Biomedical Labs.), polyclonal rabbit anti–mouse IL-12R
 
b
 
 Ab
(Santa Cruz Biotechnology, Inc.), or normal rabbit serum as a
negative control. Specimens were further developed with Rhoda-
mine-conjugated goat anti–rabbit IgG (ICN Pharmaceuticals,
Inc.). Samples on coverslips were mounted onto glass slides with
Mowiol (Calbiochem Corp.) and examined under a Fluorescence
Microscope Axiovert 100 (Carl Zeiss, Inc.) equipped with an im-
age analysis system (Signal Analytics Co.).
 
Results
 
Production of IFN-
 
g
 
 in the Sera of NK Cell–depleted Rag-2
 
2/2
 
Mice.
 
Several studies have demonstrated that IFN-
 
g
 
 pro-
duced by NK as well as Th1 cells is a crucial cytokine for
limiting and clearing infectious intracellular agents such as
protozoan and bacterial pathogens (6–8, 19–22). To examine
the role of NK cells in the early production of IFN-
 
g
 
, we
injected polyclonal 
 
a
 
ASGM1 Abs into B10.D2 or B10.D2–
Rag-22/2 mice to deplete NK cells as previously demon-
strated (23). Consistent with previous studies, NK cells were
absent in the spleen of both B10.D2 and B10.D2–Rag-22/2
mice 3 d after administration of 300 mg aASGM1 Ab (Fig.
1 A). These mice were then injected with 2 3 106 LM or
0.5 mg IL-12, and serum IFN-g levels were examined after
48 and 24 h, respectively. As shown in Fig. 1 B, IFN-g was
detected in the sera of NK cell–depleted B10.D2 mice at a
level comparable to those in untreated B10.D2 mice upon
LM infection (Fig. 1 B, top). As both T and B cells (24) are
able to produce IFN-g, we performed the same experi-
ment with B10.D2–Rag-22/2 mice lacking both T and B
cells. To our surprise, comparable levels of IFN-g were in-
duced in NK cell–depleted B10.D2–Rag-22/2 mice and in
untreated B10.D2–Rag-22/2 mice (Fig. 1 B, top).
Because IL-12 is important in inducing IFN-g, we also
injected recombinant IL-12 into these mice and observed
IFN-g production in the sera independent of NK cell deple-
tion (Fig. 1 B, top). IFN-g was not detected in the sera of
mice injected with PBS or aASGM1 alone. These data sug-1983 Ohteki et al. Brief Definitive Report
gest that the contribution of NK cells to early IFN-g pro-
duction in response to LM infection or IL-12 administration
is minimal. We further examined C57BL/6-gc
2/2(Y)Rag-22/2
mice lacking T, B, and NK cells, as well as NOD/LtSz-scid/
scid mice lacking T and B cells and having functional defects
in NK cells and monocytes/macrophages (16). After 24 h
of IL-12 administration, only a small amount of serum
IFN-g was detected in C57BL/6-gc
2/2(Y)Rag-22/2 mice,
whereas substantial amounts of IFN-g were produced by
NOD/LtSz-scid/scid mice. IFN-g production in NOD/
LtSz-scid/scid mice was also unaffected by pretreatment
with  aASGM1 Ab (Fig. 1 B, bottom, and data not shown).
To identify the IFN-g–producing cells in aASGM1-
treated Rag-22/2 mice, splenocytes were prepared from mice
treated with aASGM1 and infected LM in vitro. As shown
in Fig. 1 C, IFN-g was produced by Rag-22/2 splenocytes
in the absence of NK cells, and the production of IFN-g was
completely blocked by the addition of anti–IL-12 Ab, indi-
cating that IL-12 plays a critical role in IFN-g production
upon LM infection. These results further indicate the pres-
ence of IFN-g–producing cells other than T, B, and NK
cells. In contrast, amounts of IFN-g produced by C57BL/
6-gc
2/2(Y)Rag-22/2 splenocytes were 1–5% of those from
NK-depleted Rag-22/2 splenocytes upon either Listeria in-
fection or IL-12 administration, suggesting that IFN-g pro-
duction is impaired in C57BL/6-gc
2/2(Y)Rag-22/2 mice.
IFN-g Production by DCs. To further identify IFN-g–
producing cells, DCs as well as macrophages and NK cells
were freshly isolated from collagenase-treated spleen cells of
unprimed mice by cell sorting. Highly purified CD11c1 I-A1,
Mac11F4/801, and CD3-NK1.11 cells were used as DCs,
macrophages, and NK cells, respectively (Fig. 2 A and data
not shown). These cells were cultured for 3 d in the presence
of 1 ng/ml IL-12 in vitro. As shown in Fig. 2 B, significant
amounts of IFN-g were detected in the culture supernatants
of DCs and macrophages. The amounts of IFN-g from DCs
and macrophages were significantly higher than those from
NK cells. DCs cultured in the absence of IL-12 produced
IFN-g to a certain level, probably due to the cross-linking of
surface MHC class II molecules by the use of anti–I-A mAb
for DC preparation (25). Consistent with this interpretation,
DCs purified using anti-CD86 mAb (26) instead of anti–I-A
mAb did not produce IFN-g without IL-12 (see Fig. 3 B).
Figure 1. IFN-g production in the sera
of NK cell–depleted Rag-22/2 mice. (A)
300 mg  aASGM1 Ab were injected into
B10.D2 and B10.D2–Rag-22/2 mice.
Spleen cells were collected on day 3 and
stained for 145-2C11–PE (anti-CD3e) and
DX5-FITC (anti-pan NK). (B) Saline, 0.5
mg IL-12, or 2 3 106 LM were intraperito-
neally injected into B10.D2 or B10.D2–
Rag-22/2 mice with or without treatment
with aASGM1 3 d before injection (top),
or into C57BL/6-gc
2/2(Y)Rag-22/2 and
NOD/LtSz-scid/scid mice (bottom). Sera
were collected 24 h later from IL-12–
injected mice and 48 h later from LM-
infected and control mice, and the amounts
of IFN-g were measured by ELISA. (C) In
vitro IFN-g production from NK cell–
depleted Rag-22/2 splenocytes cultured
with LM. 106 collagenase-treated spleno-
cytes were obtained from NK cell–depleted
B10.D2, B10.D2–Rag-22/2, and C57BL/
6-gc
2/2(Y)Rag-22/2 mice. The cells were
infected with 4 3 105 LM and cultured for
3 d with or without either 10 mg/ml anti–
IL-12 mAb (top) or 1 ng/ml IL-12 (bot-
tom). The amounts of IFN-g were mea-
sured by ELISA.
Figure 2. IFN-g production from isolated DCs. (A) Isolation of splenic
DCs. CD11c1I-Ab1 DCs were isolated from C57BL/6 splenocytes on a
FACS Vantage™, and the purity of the cells was checked. (B) IFN-g
production in culture supernatants of DCs, macrophages, and NK cells.
DCs (5 3 104), NK cells (5 3 104), and macrophages (2 3 104) were cul-
tured for 3 d in the presence of 1 ng/ml IL-12. Culture supernatants were
harvested and subjected to ELISA. Asterisk indicates the amount of IFN-g
produced by 5 3 104 equivalent macrophages.1984 IFN-g Production by CD8a1 Dendritic Cells
The CD8a1 Lymphoid DC Population Is a Major Source of
IFN-g Production. There are two different types of DCs
in the spleen of an adult mouse (27–30). They differ in sur-
face phenotypes (CD8a2DEC-2052CD11b1 versus CD8a1
DEC-2051CD11b2), origin (myeloid versus lymphoid), re-
quirement of cytokines for their development (GM-CSF
versus IL-3), and biological function. To this end, we ex-
amined IFN-g production from DC subpopulations. CD8a2
DCs (myeloid DCs) and CD8a1 DCs (lymphoid DCs) were
isolated by cell sorting and cultured with 1 ng/ml IL-12 for
3 d. As shown in Fig. 3, CD8a1 DCs were found to pro-
duce an approximately fivefold higher level of IFN-g than
do CD8a2 DCs, indicating that CD8a1 lymphoid DCs are
the major IFN-g producers in response to IL-12 stimulation.
Detection of Intracellular IFN-g in DCs. Immunofluores-
cence microscopy was conducted to directly detect the
expression of IFN-g protein in DCs. Purified CD11c1
CD861 splenic DCs were cultured in the presence of IL-12
for 3 d, fixed on coverslips, and subjected to intracellular im-
munofluorescence microscopic analysis. As shown in Fig. 4,
IFN-g proteins were clearly detected in the cytoplasm of
CD11c1 DCs (Fig. 4, A and D), whereas staining was unde-
tectable with the control rabbit serum (Fig. 4, C and F).
Consistent with a previous study (31), expression of IL-12Rs
was readily observed on the cell surface of DCs (Fig. 4, B
and E). IFN-g was not detected in freshly isolated DCs but
was detected in splenic macrophages upon IL-12 stimulation
by immunofluorescence microscopy (data not shown).
Discussion
We presented here evidence that NK cells play a small
role in the production of IFN-g at early stages of LM in-
fection or IL-12 administration, and that DCs and macro-
phages produce IFN-g. Among DC subpopulations, CD8a1
lymphoid DCs are major producers of IFN-g in response
to IL-12. Recent studies have also reported the ability of
macrophages to produce IFN-g (12, 13). Amounts of IFN-g
produced by DCs and macrophages were substantially
larger than the amount produced by NK cells.
It has long been assumed that IL-12 is initially produced by
macrophages in response to various intracellular pathogens
and later by DCs (32, 33), based on the observations that DCs
produce IL-12 through ligation of CD40 on DCs by CD40L
on activated T cells, or through cross-linking of MHC class II
molecules by the TCR (25, 34). However, it has been shown
recently that phagocytosis of microparticle-adsorbed proteins
stimulates DCs to synthesize IL-12 without interacting with
T cells (35), and that DCs but not macrophages produce
IL-12 in vivo in microbial infection such as Toxoplasma gondii
(36). Furthermore, accumulating evidence has indicated that
resting macrophages are unable to produce IL-12 in response
to bacteria or microbial products such as LPS without prior
activation by certain cytokines such as IFN-g (4, 37, 38).
In this paper we showed that DCs are able to produce
IFN-g upon IL-12 stimulation. Because DCs produce IL-12
upon phagocytosis and microbial infection, and IL-12 in turn
augments the production of IL-12 itself from DCs (31, 35,
36), it is likely that DCs produce IL-12 and IFN-g by an
autocrine manner once they have been triggered by micro-
bial infection. The fact that the addition of anti–IL-12 Ab
completely blocked the IFN-g production by NK cell–
depleted Rag-22/2 splenocytes upon LM infection supports
Figure 3. IFN-g production by DC subpopulations. (A) Isolated splenic
DCs were stained with anti-CD11c–FITC, anti-CD8a–PE, and anti-CD86–
biotin, followed by streptavidin–Red 670, and subjected to cell sorting to pu-
rify CD8a2CD11c1CD861 (myeloid) DCs and CD8a1CD11c1CD861
(lymphoid) DCs. Purity of CD11c1CD861 whole DCs, CD8a2 DCs and
CD8a1 DCs were 98, 95, and 90%, respectively. (B) Whole DCs,
CD8a2CD11c1CD861 DCs, and CD8a1 CD11c1CD861 DCs (5 3 104)
were cultured for 3 d in the presence of 1 ng/ml IL-12, and the amounts of
IFN-g in culture supernatants were measured by ELISA. No difference in vi-
ability was observed between CD8a1 and CD8a2 DCs.
Figure 4. Detection of intra-
cellular IFN-g in IL-12–stimu-
lated DCs. Purified DCs were
cultured in the presence of 1 ng
IL-12 for 3 d. After surface stain-
ing with FITC-conjugated mAb
against CD11c, cells were fixed
and permeabilized. Cells were
then incubated with rabbit poly-
clonal Ab against IFN-g (A and
B) and normal rabbit serum (E
and F). Freshly isolated DCs
were also incubated with rabbit
polyclonal Ab against IL-12R (C
and D). Samples were further
stained with Rhodamine-conju-
gated goat anti-rabbit IgG. Bars,
10 mm.1985 Ohteki et al. Brief Definitive Report
this notion. In addition to IL-12, IL-18 and IL-1b are also
likely to be involved in augmenting IFN-g production
from DCs in vivo, as observed in T and NK cells (39, 40).
Our results on C57BL/6-gc
2/2(Y)Rag-22/2 mice are con-
sistent with a recent paper by Andersson et al. that reports
that gc
2/2(Y)Rag-22/2 mice produce minimal amount of
IFN-g (41). Since these mice lack NK cells as well as T and
B cells, it was concluded that NK cells are the major produc-
ers of IFN-g. Flow cytometric analysis showed the presence
of normal numbers of DCs and macrophages in the spleens
of C57BL/6-gc
2/2(Y)Rag-22/2 mice (Ohteki, T., and S.
Koyasu, unpublished results). It is likely that APCs in the
gc
2/2(Y)Rag-22/2 mice have some functional rather than
developmental defects that remain to be examined.
It is likely that the IFN-g derived from DCs plays a key
role in priming and activating macrophages to produce
IL-12 in response to intracellular pathogens. DC-derived
IFN-g, together with IL-12, may also be important in up-
regulation of surface molecules on DCs such as MHC class
II. Once IL-12 and IFN-g are produced by DCs, a positive
feedback pathway(s) would be activated between DCs and
macrophages even in the absence of NK cell–derived IFN-g.
Macrophages then secrete IFN-g in response to IL-12 or a
combination of IL-12 and IL-18 (12, 13), which also acti-
vates macrophages in an autocrine manner to produce ni-
tric oxide. In microbial infection such pathways would be
quicker than the pathway through NK cell–derived IFN-g,
and thus important, although not sufficient, for an early
stage of innate immune response.
DCs are divided into at least two subpopulations by ori-
gins, surface molecules, and the requirement of cytokines for
their development (27–30). One subpopulation is myeloid
DCs without CD8a expression, and the second is lymphoid
DCs expressing CD8a. It has been shown that CD8a1 lym-
phoid DCs primarily produce IL-12 in vivo in intracellular
protozoan infection (36). Given that the CD8a1 DCs pro-
duce IFN-g in response to IL-12 (Fig. 3) and predominantly
localized in the T cell area of the spleen (30), lymphoid
CD8a1 DCs rather than myeloid CD8a2 DCs are probably
the most efficient initiators for innate immune response
upon infection of intracellular microorganisms, as well as the
directors of subsequent Th1 differentiation in vivo.
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